TCPG
MDT icon

Trivant Custom Portfolio Group’s Medtronic MDT Stock Holding History

Trivant Custom Portfolio Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-310
Closed -$27.3K – 205
2023
Q2 		$27.3K Sell
310
-71
-19% -$6.11K 0.02% 135
2023
Q1 		$30.7K Buy
+381
New +$31.1K 0.02% 142

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trivant Custom Portfolio Group's MDT Position: Q3 2023 in Review

Trivant Custom Portfolio Group sold out of Medtronic (MDT) in Q3 2023, closing a stake of 310 shares — an estimated $27.3K sold.

Trivant Custom Portfolio Group first reported a position in MDT in Q1 2023 and held it in 2 quarters. The position peaked at $30.7K in Q1 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Trivant Custom Portfolio Group reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Trivant Custom Portfolio Group sold 310 Medtronic shares in Q3 2023, an estimated $27.3K.
  • Trivant Custom Portfolio Group first reported a position in Medtronic in Q1 2023 and held it in 2 quarters.
  • Trivant Custom Portfolio Group's Medtronic position peaked at $30.7K in Q1 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Trivant Custom Portfolio Group's 13F filing for Q3 2023, filed 2 Nov 2023.